These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1812944)

  • 1. Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.
    Harrington WJ; Sheremata WA; Snodgrass SR; Emerson S; Phillips S; Berger JR
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1031-4. PubMed ID: 1812944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol. A new perspective in the treatment of HTLV-1 associated myelopathy (preliminary report).
    Melo A; Moura L; Meireles A; Costa G
    Arq Neuropsiquiatr; 1992 Sep; 50(3):402-3. PubMed ID: 1308424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
    Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
    J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
    Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
    Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
    Nakagawa M; Nakahara K; Maruyama Y; Kawabata M; Higuchi I; Kubota H; Izumo S; Arimura K; Osame M
    J Neurovirol; 1996 Oct; 2(5):345-55. PubMed ID: 8912211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Araújo AQ; Afonso CR; Leite AC; Dultra SV
    Arq Neuropsiquiatr; 1993 Sep; 51(3):325-8. PubMed ID: 8297234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropical spastic paraparesis treated with Combivir (lamivudine-zidovudine).
    Hassan S; Amer S; Zervos M
    J Clin Neurosci; 2013 May; 20(5):759-60. PubMed ID: 23477875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.